Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review.

Alsanosi ZY, Alshahrani AS, Nammazi AA, Alsunusi OA, Moafa AA, Hadi IH, Alabdali AA, Alhaqbani AW, Shahat RA, Albeladi SA, Almajdoa AA

Open source

DOI
10.7759/cureus.114350
Published
2026 Aug
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.114350,
  title = {Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review.},
  author = {Alsanosi ZY and Alshahrani AS and Nammazi AA and Alsunusi OA and Moafa AA and Hadi IH and Alabdali AA and Alhaqbani AW and Shahat RA and Albeladi SA and Almajdoa AA},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.114350},
  url = {https://doi.org/10.7759/cureus.114350}
}

RIS

TY  - JOUR
TI  - Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review.
AU  - Alsanosi ZY
AU  - Alshahrani AS
AU  - Nammazi AA
AU  - Alsunusi OA
AU  - Moafa AA
AU  - Hadi IH
AU  - Alabdali AA
AU  - Alhaqbani AW
AU  - Shahat RA
AU  - Albeladi SA
AU  - Almajdoa AA
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.114350
UR  - https://doi.org/10.7759/cureus.114350
ER  - 

APA

ZY, A., AS, A., AA, N., OA, A., AA, M., IH, H., AA, A., AW, A., RA, S., SA, A., & AA, A. (2026). Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review.. Cureus. https://doi.org/10.7759/cureus.114350

Source records